BioPharma
12 June, 2025 | Thursday | News
Cytiva’s $1.6B Expansion Across 3 Continents to Boost Bioprocessing Supply
Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and cell culture Most major projects compl...
Lab
03 June, 2025 | Tuesday | News
Thermo Fisher Launches Orbitrap Astral Zoom and Excedion Pro MS to Accelerate Precision Research in Alzheimer's, Cancer, and Biopharma
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Therm...
BioTech
11 June, 2025 | Wednesday | News
Alamar Biosciences, Gates Ventures, and Alzheimer's Disease Data Initiative Launch Global Effort to Build Largest Plasma Proteome Atlas for Alzheimer’s
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and Gates Ventures announced a strategic partnership with the goa...
Contract Services
06 June, 2025 | Friday | News
SCHOTT Pharma Breaks Ground on €100M RTU Cartridge Facility in Hungary to Boost Supply Across Europe
SCHOTT Pharma breaks ground for a new production facility for ready-to-use cartridges in Hungary Its investment of over EUR 100 million is part of the company’s expansion strategy to meet...
Consumer Health
04 June, 2025 | Wednesday | News
Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms
Astellas Singapore has announced that the Health Sciences Authority (HSA) of Singapore has approved VEOZA™ (fezolinetant) 45 mg for the treatment of moderate to severe vasomotor symptoms (VMS) associated ...
White Paper
06 June, 2025 | Friday | Report
ASCO 2025 Showcases New Oncology Paradigms, From Breast Cancer Breakthroughs to AI-Led Precision Medicine
Product Spot Light
05 June, 2025 | Thursday | News
Continuity Biosciences Acquires Focal Medical to Advance Site-Specific Chemotherapy for Pancreatic Cancer
Premium Article
23 May, 2025 | Friday | Interview
Closer to Customers, Stronger in Supply: Oliver’s APAC Leader on Malaysia Facility and Future Plans
Bio Invest
12 June, 2025 | Thursday | News
Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases
Biopharma APAC Infomercial
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
